ABP 215 (Bevacizumab-awwb), a biosimilar to Bevacizumab, is a humanized IgG1 monoclonal antibody that specifically targets vascular endothelial growth factor A (VEGFA), thereby inhibiting its interaction with VEGF receptors. This antibody demonstrates anticancer properties by impeding angiogenesis, a critical process in tumor growth and metastasis. ABP 215 is utilized in research focused on metastatic colorectal cancer (mCRC), providing a valuable tool for investigating disease mechanisms and potential therapeutic interventions.
ABP 215 (Bevacizumab-awwb), a biosimilar to Bevacizumab, is a humanized IgG1 monoclonal antibody that specifically targets vascular endothelial growth factor A (VEGFA), thereby inhibiting its interaction with VEGF receptors. This antibody demonstrates anticancer properties by impeding angiogenesis, a critical process in tumor growth and metastasis. ABP 215 is utilized in research focused on metastatic colorectal cancer (mCRC), providing a valuable tool for investigating disease mechanisms and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
